|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5428156A
(en)
|
1993-04-02 |
1995-06-27 |
Associated Universities, Inc. |
Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging
|
|
US5707624A
(en)
|
1994-06-03 |
1998-01-13 |
The Regents Of The University Of Michigan |
Treatment of Kaposi's sarcoma by inhibition of scatter factor
|
|
US6214344B1
(en)
|
1995-06-02 |
2001-04-10 |
Genetech, Inc. |
Hepatocyte growth factor receptor antagonists and uses thereof
|
|
US5646036A
(en)
|
1995-06-02 |
1997-07-08 |
Genentech, Inc. |
Nucleic acids encoding hepatocyte growth factor receptor antagonist antibodies
|
|
US5686292A
(en)
|
1995-06-02 |
1997-11-11 |
Genentech, Inc. |
Hepatocyte growth factor receptor antagonist antibodies and uses thereof
|
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
|
IL127558A0
(en)
|
1996-07-03 |
1999-10-28 |
Genentech Inc |
Hepatocyte growth factor receptor agonists and uses thereof
|
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
|
US20070258987A1
(en)
|
2000-11-28 |
2007-11-08 |
Seattle Genetics, Inc. |
Recombinant Anti-Cd30 Antibodies and Uses Thereof
|
|
WO2004072117A2
(en)
|
2003-02-13 |
2004-08-26 |
Pharmacia Corporation |
Antibodies to c-met for the treatment of cancers
|
|
ITMI20031127A1
(it)
|
2003-06-05 |
2004-12-06 |
Uni Degli Studi Del Piemont E Orientale Am |
Anticorpi anti-hgf-r e loro uso
|
|
MXPA05013181A
(es)
|
2003-06-06 |
2006-06-23 |
Genentech Inc |
Metodos y composiciones para modular hgf/met.
|
|
HN2004000285A
(es)
|
2003-08-04 |
2006-04-27 |
Pfizer Prod Inc |
ANTICUERPOS DIRIGIDOS A c-MET
|
|
US20050233960A1
(en)
*
|
2003-12-11 |
2005-10-20 |
Genentech, Inc. |
Methods and compositions for inhibiting c-met dimerization and activation
|
|
KR100956913B1
(ko)
|
2003-12-19 |
2010-05-11 |
제넨테크, 인크. |
치료제로서 유용한 일가 항체 단편
|
|
EP1718667B1
(en)
|
2004-02-23 |
2013-01-09 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
AR048098A1
(es)
|
2004-03-15 |
2006-03-29 |
Wyeth Corp |
Conjugados de caliqueamicina
|
|
EP1773885B1
(en)
|
2004-08-05 |
2010-04-21 |
Genentech, Inc. |
Humanized anti-cmet antagonists
|
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
|
US20070134243A1
(en)
|
2004-12-01 |
2007-06-14 |
Gazzard Lewis J |
Antibody drug conjugates and methods
|
|
WO2006104911A2
(en)
|
2005-03-25 |
2006-10-05 |
Genentech, Inc. |
Methods and compositions for modulating hyperstabilized c-met
|
|
US7714016B2
(en)
|
2005-04-08 |
2010-05-11 |
Medarex, Inc. |
Cytotoxic compounds and conjugates with cleavable substrates
|
|
CN101360511A
(zh)
|
2005-11-16 |
2009-02-04 |
法里巴·内耶里 |
用内源c-met配体和抑制剂抑制个体中的癌发生和/或转移的方法
|
|
CA2638889C
(en)
|
2006-02-06 |
2015-06-02 |
Metheresis Translational Research S.A. |
Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
ES2369739T3
(es)
|
2006-03-20 |
2011-12-05 |
Seikagaku Corporation |
Agente terapéutico para la artritis reumatoide.
|
|
EP2004693B1
(en)
|
2006-03-30 |
2012-06-06 |
Novartis AG |
Compositions and methods of use for antibodies of c-met
|
|
ES2398076T3
(es)
|
2006-06-02 |
2013-03-13 |
Regeneron Pharmaceuticals, Inc. |
Anticuerpos de alta afinidad contra el receptor de IL-6 humano
|
|
KR100829972B1
(ko)
|
2006-07-14 |
2008-05-16 |
재단법인서울대학교산학협력재단 |
항-ｈｇｆ/ｓｆ 인간화 항체 및 이의 제조방법
|
|
NO347649B1
(no)
|
2006-12-14 |
2024-02-12 |
Regeneron Pharma |
Humant antistoff eller antistoff fragment som spesifikt binder human deltaliknende ligand 4 (hDII4), nukleinsyremolekyl som koder for slike og vektor og vert-vektorsystemer, samt fremgangsmåte for fremstilling, sammensetning og anvendelse.
|
|
US8039598B2
(en)
|
2007-01-19 |
2011-10-18 |
Van Andel Research Institute |
Met fab and SCFV fragments
|
|
WO2008122039A2
(en)
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
|
JP2010528285A
(ja)
|
2007-05-23 |
2010-08-19 |
ベンタナ・メデイカル・システムズ・インコーポレーテツド |
免疫組織化学およびｉｎｓｉｔｕハイブリダーゼーションのためのポリマー担体
|
|
EP2014681A1
(en)
|
2007-07-12 |
2009-01-14 |
Pierre Fabre Medicament |
Novel antibodies inhibiting c-met dimerization, and uses thereof
|
|
US7892770B2
(en)
|
2007-08-24 |
2011-02-22 |
Van Andel Research Institute |
Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods
|
|
US20110104166A1
(en)
|
2008-01-18 |
2011-05-05 |
Stankovic Konstantina M |
Methods and Compositions for Treating Polyps
|
|
RU2601892C2
(ru)
|
2008-03-06 |
2016-11-10 |
Дженентек, Инк. |
Комбинированная терапия антагонистами с-мет и egfr
|
|
EP2260056A1
(en)
|
2008-03-06 |
2010-12-15 |
Genentech, Inc. |
Combination therapy with c-met and her antagonists
|
|
EP2276506A4
(en)
|
2008-04-30 |
2014-05-07 |
Immunogen Inc |
EFFICIENT CONJUGATES AND HYDROPHILIC BINDER
|
|
EP2288383A1
(en)
|
2008-05-14 |
2011-03-02 |
Amgen, Inc |
Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer
|
|
US8455623B2
(en)
|
2008-05-21 |
2013-06-04 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
|
EP2127683A1
(en)
|
2008-05-29 |
2009-12-02 |
Metheresis Translational Research SA |
Anti-Met monoclonal antibody, fragments and derivatives thereof for use in tumor imaging, corresponding compositions and kits
|
|
US20090297439A1
(en)
|
2008-06-02 |
2009-12-03 |
Metheresis Translational Research Sa, |
Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis, corresponding compositions and kits
|
|
EP2143441A1
(en)
|
2008-07-08 |
2010-01-13 |
Pierre Fabre Medicament |
Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer
|
|
EP2374481B1
(en)
|
2008-07-21 |
2015-11-04 |
Polytherics Limited |
Novel reagents and method for conjugating biological molecules
|
|
WO2010039248A1
(en)
|
2008-10-01 |
2010-04-08 |
Ludwig Institute For Cancer Research |
Methods for the treatment of cancer
|
|
MX2011004050A
(es)
|
2008-10-17 |
2011-05-10 |
Genentech Inc |
Metodo de tratamiento.
|
|
WO2010045344A1
(en)
|
2008-10-17 |
2010-04-22 |
Genentech, Inc. |
Combination therapy comprising a c-met antagonist and a vegf antagonist
|
|
PA8849001A1
(es)
|
2008-11-21 |
2010-06-28 |
Lilly Co Eli |
Anticuerpos de c-met
|
|
US9469691B2
(en)
|
2008-12-02 |
2016-10-18 |
Pierre Fabre Medicament |
Anti-cMET antibody
|
|
AR074439A1
(es)
|
2008-12-02 |
2011-01-19 |
Pf Medicament |
Anticuerpo anti-cmet (receptor c-met)
|
|
US8545839B2
(en)
|
2008-12-02 |
2013-10-01 |
Pierre Fabre Medicament |
Anti-c-Met antibody
|
|
MX2011010166A
(es)
|
2009-04-07 |
2011-10-11 |
Roche Glycart Ag |
Anticuerpos biespecificos anti-erbb-3/anti-c-met.
|
|
BRPI1014449A2
(pt)
|
2009-04-07 |
2017-06-27 |
Roche Glycart Ag |
anticorpos biespecíficos anti-erbb-2/ anti-c-met.
|
|
JO3182B1
(ar)
|
2009-07-29 |
2018-03-08 |
Regeneron Pharma |
مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2
|
|
JP5954789B2
(ja)
|
2009-08-10 |
2016-07-20 |
ユーシーエル ビジネス パブリック リミテッド カンパニー |
機能的分子の可逆的共有結合
|
|
EP2287197A1
(en)
|
2009-08-21 |
2011-02-23 |
Pierre Fabre Medicament |
Anti-cMET antibody and its use for the detection and the diagnosis of cancer
|
|
KR101671378B1
(ko)
|
2009-10-30 |
2016-11-01 |
삼성전자 주식회사 |
ｃ-Ｍｅｔ에 특이적으로 결합하는 항체 및 그의 용도
|
|
KR101748707B1
(ko)
|
2009-11-27 |
2017-06-20 |
삼성전자주식회사 |
ｃ-Ｍｅｔ에 특이적으로 결합하는 항체 및 그를 이용한 암 진단용 키트
|
|
EP3511342B1
(en)
|
2010-03-10 |
2024-01-17 |
Genmab A/S |
Monoclonal antibodies against c-met
|
|
DK2528625T3
(da)
|
2010-04-15 |
2013-10-14 |
Spirogen Sarl |
Pyrrolobenzodiazepiner og konjugater deraf
|
|
WO2011143665A1
(en)
|
2010-05-14 |
2011-11-17 |
Genentech, Inc. |
Treatment methods
|
|
AU2011261161A1
(en)
*
|
2010-06-01 |
2013-01-10 |
Ludwig Institute For Cancer Research Limited |
Antibodies directed to the unprocessed receptor tyrosine kinase c-Met
|
|
EP2402370A1
(en)
|
2010-06-29 |
2012-01-04 |
Pierre Fabre Médicament |
Novel antibody for the diagnosis and/or prognosis of cancer
|
|
US20130315895A1
(en)
|
2010-07-01 |
2013-11-28 |
Takeda Pharmaceutical Company Limited |
COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
|
|
US20130244905A1
(en)
|
2010-07-06 |
2013-09-19 |
Ed Grabczyk |
Reporter for RNA Polymerase II Termination
|
|
KR20140019284A
(ko)
|
2010-09-03 |
2014-02-14 |
아카데미아 시니카 |
항-C-Met 항체 및 이의 이용 방법들
|
|
EP2635602B1
(en)
|
2010-11-03 |
2016-09-07 |
Argen-X Nv |
Anti c-met antibodies
|
|
DK2500036T3
(da)
|
2011-03-18 |
2014-08-04 |
Metheresis Translational Res Sa |
MET-hæmmere til øgning af virkningen af radioterapi
|
|
WO2012136685A1
(en)
|
2011-04-04 |
2012-10-11 |
Pieris Ag |
Methods and compositions for anti-vegf and anti-c-met therapy
|
|
KR20120130658A
(ko)
|
2011-05-23 |
2012-12-03 |
주식회사 파멥신 |
펩타이드가 융합된 이중표적항체 및 그 용도
|
|
KR20140037105A
(ko)
|
2011-05-27 |
2014-03-26 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
|
|
KR101444837B1
(ko)
|
2011-06-03 |
2014-09-30 |
한국생명공학연구원 |
ＨＧＦ 활성을 가지는 ｃ-Ｍｅｔ에 대한 인간항체 및 이의 용도
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
RU2013155695A
(ru)
|
2011-06-30 |
2015-08-10 |
Дженентек, Инк. |
Препараты антител против с-мет
|
|
AU2012312515A1
(en)
|
2011-09-19 |
2014-03-13 |
Genentech, Inc. |
Combination treatments comprising c-met antagonists and B-raf antagonists
|
|
CA2843771A1
(en)
|
2011-09-20 |
2013-03-28 |
Eli Lilly And Company |
Anti-c-met antibodies
|
|
CN103889451B
(zh)
*
|
2011-09-30 |
2016-06-29 |
埃博灵克斯股份有限公司 |
与C-Met相关的生物物质
|
|
KR20130037153A
(ko)
|
2011-10-05 |
2013-04-15 |
삼성전자주식회사 |
항 ｃ-Ｍｅｔ 항체 및 그의 용도
|
|
KR101865223B1
(ko)
|
2011-10-05 |
2018-06-08 |
삼성전자주식회사 |
항 ｃ-Ｍｅｔ 인간화 항체 및 그의 용도
|
|
KR20130036993A
(ko)
|
2011-10-05 |
2013-04-15 |
삼성전자주식회사 |
ｃ-Ｍｅｔ의 ＳＥＭＡ 도메인 내의 에피토프에 특이적으로 결합하는 항체
|
|
ES2945932T3
(es)
|
2011-10-14 |
2023-07-10 |
Seagen Inc |
Pirrolobenzodiazepinas y conjugados dirigidos
|
|
CA2850096C
(en)
|
2011-10-14 |
2018-07-03 |
Spirogen Sarl |
Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
|
|
WO2013055993A1
(en)
|
2011-10-14 |
2013-04-18 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
CA2850103C
(en)
|
2011-10-14 |
2019-09-10 |
Spirogen Sarl |
Pyrrolobenzodiazepines
|
|
GB2504139B
(en)
*
|
2012-07-20 |
2014-12-31 |
Argen X Bv |
Antibodies to highly conserved targets produced by the immunisation of Camelidae species
|
|
WO2013068874A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
Antibody-drug conjugates
|
|
KR101844479B1
(ko)
|
2011-11-17 |
2018-04-03 |
삼성전자주식회사 |
항 ｃ-Ｍｅｔ 항체 및 그의 용도
|
|
EP2782932A1
(en)
|
2011-11-21 |
2014-10-01 |
F.Hoffmann-La Roche Ag |
Purification of anti-c-met antibodies
|
|
KR101463098B1
(ko)
|
2011-11-28 |
2014-11-27 |
한국생명공학연구원 |
ｃ-Ｍｅｔ에 대한 인간항체에 약물이 접합된 약물 복합체 및 이의 용도
|
|
CN104244718A
(zh)
|
2011-12-05 |
2014-12-24 |
伊格尼卡生物治疗公司 |
抗体-药物缀合物以及相关化合物、组合物和方法
|
|
KR101910601B1
(ko)
|
2011-12-22 |
2018-10-23 |
삼성전자주식회사 |
면역원성이 제거된 항 ｃ-Ｍｅｔ 인간화 항체 및 그의 용도
|
|
MX361875B
(es)
|
2012-03-14 |
2018-12-18 |
Regeneron Pharma |
Moléculas de unión de antígeno multiespecifícas y usos de las mismas.
|
|
WO2013152252A1
(en)
|
2012-04-06 |
2013-10-10 |
OSI Pharmaceuticals, LLC |
Combination anti-cancer therapy
|
|
JP6129956B2
(ja)
|
2012-05-09 |
2017-05-17 |
イーライ リリー アンド カンパニー |
抗ｃ−Ｍｅｔ抗体
|
|
US20150182622A1
(en)
|
2012-06-14 |
2015-07-02 |
The Schepens Eye Research Institute |
Treatment and prevention of retinal injury and scarring
|
|
WO2013192594A2
(en)
|
2012-06-21 |
2013-12-27 |
Sorrento Therapeutics Inc. |
Antigen binding proteins that bind c-met
|
|
KR101938698B1
(ko)
|
2012-07-23 |
2019-01-16 |
삼성전자주식회사 |
Ｃｂｌ의 항 ｃ－ｍｅｔ 항체 적용 대상 환자 선별을 위한 바이오마커로서의 용도
|
|
EP2708556B1
(en)
|
2012-09-12 |
2018-11-07 |
Samsung Electronics Co., Ltd |
Pharmaceutical composition for the use in a combination therapy for prevention or treatment of c-met or angiogenesis factor induced diseases
|
|
FI2911699T4
(fi)
|
2012-10-23 |
2025-12-09 |
Synaffix Bv |
Muokattu vasta-aine, vasta-ainekonjugaatti ja menetelmä niiden valmistamiseksi
|
|
CN113201073A
(zh)
|
2012-11-21 |
2021-08-03 |
詹森生物科技公司 |
双特异性EGFR/c-Met抗体
|
|
US9695228B2
(en)
|
2012-11-21 |
2017-07-04 |
Janssen Biotech, Inc. |
EGFR and c-Met fibronectin type III domain binding molecules
|
|
US10407503B2
(en)
|
2012-11-30 |
2019-09-10 |
The Regents Of The University Of California |
Fully human antibodies and fragments recognizing human c-Met
|
|
TWI682941B
(zh)
|
2013-02-01 |
2020-01-21 |
美商再生元醫藥公司 |
含嵌合恆定區之抗體
|
|
TW201444872A
(zh)
|
2013-03-06 |
2014-12-01 |
Merrimack Pharmaceuticals Inc |
抗Ｃ－ＭＥＴ串聯Ｆｃ雙特異性抗體
|
|
US9481725B2
(en)
|
2013-03-14 |
2016-11-01 |
Alderbio Holdings, Llc |
Antibodies to HGF and compositions containing
|
|
US9732150B2
(en)
|
2013-03-14 |
2017-08-15 |
Alderbio Holdings Llc |
Therapeutic use of antibodies to HGF
|
|
US9062104B2
(en)
|
2013-03-14 |
2015-06-23 |
Alderbio Holdings Llc |
Therapeutic use of antibodies to HGF
|
|
MX379256B
(es)
*
|
2013-03-15 |
2025-03-10 |
Regeneron Pharma |
Moleculas biologicamente activas, conjugados de las mismas, y usos terapeuticos.
|
|
KR102029137B1
(ko)
|
2013-03-27 |
2019-10-08 |
삼성전자주식회사 |
EGFR 길항제 및 항 c-Met 항체를 포함하는 병용 투여용 약학 조성물
|
|
US9535055B2
(en)
|
2013-03-28 |
2017-01-03 |
Samsung Electronics Co., Ltd. |
Marker for determining effects of anti-c-Met antibody and method of determining effects of anti-c-Met antibody using the marker
|
|
KR102049991B1
(ko)
|
2013-03-28 |
2019-12-02 |
삼성전자주식회사 |
항 c-Met/항 Her2 이중 특이 항체
|
|
KR102049990B1
(ko)
|
2013-03-28 |
2019-12-03 |
삼성전자주식회사 |
c-Met 항체 및 VEGF 결합 단편이 연결된 융합 단백질
|
|
KR102042174B1
(ko)
|
2013-03-29 |
2019-11-08 |
삼성전자주식회사 |
인간화 및 친화도 성숙된 항 ｃ-Ｍｅｔ 항체 및 그의 용도
|
|
KR102074421B1
(ko)
|
2013-03-29 |
2020-02-10 |
삼성전자주식회사 |
항 c-Met/항 EGFR 이중 특이 항체
|
|
EP2786764B1
(en)
|
2013-04-01 |
2017-03-08 |
Samsung Electronics Co., Ltd. |
Combination therapy using anti-c-met antibody and sorafenib
|
|
EP2786765B1
(en)
|
2013-04-01 |
2018-10-03 |
Samsung Electronics Co., Ltd. |
Composition for combination therapy comprising an anti-C-met antibody and a FGFR inhibitor
|
|
US10214593B2
(en)
|
2013-04-02 |
2019-02-26 |
Samsung Electronics Co., Ltd. |
Anti-idiotype antibody against anti-c-MET antibody
|
|
EP2787008B1
(en)
|
2013-04-02 |
2019-09-04 |
Samsung Electronics Co., Ltd. |
Anti-idiotype antibody against anti-C-met antibody
|
|
KR102060540B1
(ko)
|
2013-04-03 |
2019-12-31 |
삼성전자주식회사 |
항 c-Met 항체 및 항 Ang2 항체를 포함하는 병용 투여용 약학 조성물
|
|
EP2992019B1
(en)
|
2013-04-30 |
2019-03-06 |
Agency For Science, Technology And Research |
Mab 2 anti-met antibody
|
|
KR101536668B1
(ko)
|
2013-06-18 |
2015-07-15 |
사회복지법인 삼성생명공익재단 |
인간 및 마우스 c-Met에 교차결합하는 항체 및 그의 용도
|
|
US9567641B2
(en)
|
2013-07-03 |
2017-02-14 |
Samsung Electronics Co., Ltd. |
Combination therapy for the treatment of cancer using an anti-C-met antibody
|
|
EP2824113B1
(en)
|
2013-07-09 |
2017-05-03 |
Samsung Electronics Co., Ltd |
Biomarker for selecting a subject for application of an anti-c-met antibody
|
|
KR102089591B1
(ko)
|
2013-07-29 |
2020-03-18 |
삼성전자주식회사 |
항 EGFR scFv 단편 및 이를 포함하는 항 c-Met/항 EGFR 이중 특이 항체
|
|
KR102252925B1
(ko)
*
|
2013-08-26 |
2021-05-18 |
리제너론 파마슈티칼스 인코포레이티드 |
마크롤라이드 디아스테레오머를 포함하는 약제학적 조성물, 이의 합성 방법 및 치료학적 용도
|
|
US9717715B2
(en)
|
2013-11-15 |
2017-08-01 |
Samsung Electronics Co., Ltd. |
Method of combination therapy using an anti-C-Met antibody
|
|
KR102178323B1
(ko)
|
2013-11-29 |
2020-11-13 |
삼성전자주식회사 |
항 c-Met/항 Ang2 이중 특이 항체
|
|
US9562059B2
(en)
|
2013-12-02 |
2017-02-07 |
Hong Kong Baptist University |
Anticancer maytansinoids with two fused macrocyclic rings
|
|
TW201609805A
(zh)
|
2013-12-23 |
2016-03-16 |
美國禮來大藥廠 |
結合ｅｇｆｒ及ｍｅｔ之多功能抗體
|
|
KR20150083689A
(ko)
|
2014-01-10 |
2015-07-20 |
삼성전자주식회사 |
항 c-Met 항체 정제 방법
|
|
KR102194142B1
(ko)
|
2014-01-20 |
2020-12-23 |
삼성전자주식회사 |
항 c-Met/항 EGFR 이중 특이 항체 및 c-Src 저해제를 포함하는 병용 투여용 약학 조성물
|
|
KR102127408B1
(ko)
|
2014-01-29 |
2020-06-29 |
삼성전자주식회사 |
항 Her3 scFv 단편 및 이를 포함하는 항 c-Met/항 Her3 이중 특이 항체
|
|
EP3131585B1
(en)
|
2014-03-19 |
2020-07-15 |
Universität Zürich |
Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy
|
|
EP2937421B1
(en)
|
2014-04-03 |
2018-10-24 |
Samsung Electronics Co., Ltd |
Biomarker for predicting effect of an anti-C-met antibody
|
|
KR102223502B1
(ko)
|
2014-05-09 |
2021-03-05 |
삼성전자주식회사 |
항 c-Met/항 EGFR/항 Her3 다중 특이 항체 및 이의 이용
|
|
US9975960B2
(en)
|
2014-05-09 |
2018-05-22 |
Samsung Electronics Co., Ltd. |
Anti-HER2 antibody and anti-c-Met/anti-HER2 bispecific antibodies comprising the same
|
|
US20170233489A1
(en)
|
2014-05-26 |
2017-08-17 |
Samsung Electronics Co., Ltd. |
Composition for combination therapy comprising anti-her2 antibody and anti-c-met antibody
|
|
KR101615619B1
(ko)
|
2014-08-07 |
2016-04-26 |
주식회사 파멥신 |
c-Met 특이적 인간 항체 및 그 제조방법
|
|
KR102259232B1
(ko)
|
2014-08-25 |
2021-05-31 |
삼성전자주식회사 |
항 c-Met/항 Ang2 이중 특이 항체
|
|
US10450376B2
(en)
|
2014-09-16 |
2019-10-22 |
Symphogen A/S |
Anti-MET antibodies and compositions
|
|
KR102390359B1
(ko)
|
2014-09-29 |
2022-04-22 |
삼성전자주식회사 |
폴리펩타이드, 이를 포함하는 항 VEGF 항체 및 항 c-Met/항 VEGF 이중 특이 항체
|
|
WO2016060297A1
(ko)
|
2014-10-16 |
2016-04-21 |
주식회사 파멥신 |
VEGFR-2 및 c-Met에 대하여 결합성을 갖는 이중표적항체
|
|
MA41022A
(fr)
|
2014-11-24 |
2017-10-03 |
Shire Human Genetic Therapies |
Ciblage lysosomial et utilisations correspondantes
|
|
EA201791203A1
(ru)
|
2014-12-08 |
2018-04-30 |
Сорренто Терапьютикс, Инк. |
ЛЕКАРСТВЕННЫЙ КОНЪЮГАТ АНТИТЕЛА ПРОТИВ с-МЕТ
|
|
CN107613974B
(zh)
|
2015-03-16 |
2021-01-15 |
塞尔德克斯医疗公司 |
抗-met抗体及其使用方法
|
|
EA034950B1
(ru)
|
2015-03-27 |
2020-04-09 |
Регенерон Фармасьютикалз, Инк. |
Производные майтанзиноида, их конъюгаты и способы использования
|
|
CN106188293A
(zh)
|
2015-04-17 |
2016-12-07 |
江苏恒瑞医药股份有限公司 |
抗c-Met抗体和抗c-Met抗体-细胞毒性药物偶联物及其医药用途
|
|
CN108350078A
(zh)
|
2015-11-03 |
2018-07-31 |
默克专利股份公司 |
用于提高肿瘤选择性和抑制的双特异性抗体及其用途
|
|
US10301395B2
(en)
|
2015-11-18 |
2019-05-28 |
Sorrento Therapeutics, Inc. |
Chemically-locked bispecific antibodies
|
|
WO2017132173A1
(en)
|
2016-01-25 |
2017-08-03 |
Regeneron Pharmaceuticals, Inc. |
Maytansinoid derivatives, conjugates thereof, and methods of use
|
|
JP6669882B2
(ja)
|
2016-02-05 |
2020-03-18 |
ヘリックスミス カンパニー リミテッド |
抗−ｃ−ＭＥＴ抗体及びその用途
|
|
RS61659B1
(sr)
|
2016-05-17 |
2021-04-29 |
Abbvie Biotherapeutics Inc |
Konjugati antitelo lek anti-cmet i metode za njihovu upotrebu
|
|
HUE054571T2
(hu)
|
2016-09-14 |
2021-09-28 |
Merck Patent Gmbh |
Hatékony tumorgátlásra szolgáló C-MET elleni ellenanyagok és ellenanyag-drog konjugátumaik
|
|
WO2018069851A2
(en)
|
2016-10-11 |
2018-04-19 |
Sorrento Therapeutics, Inc. |
C-met antibody drug conjugate
|
|
BR112019006994A2
(pt)
|
2016-10-14 |
2019-06-25 |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
uso médico de conjugado de fármaco citotóxico com anticorpo anti-c met
|
|
TWI782930B
(zh)
*
|
2016-11-16 |
2022-11-11 |
美商再生元醫藥公司 |
抗ｍｅｔ抗體，結合ｍｅｔ之雙特異性抗原結合分子及其使用方法
|
|
HUE054500T2
(hu)
|
2016-11-23 |
2021-09-28 |
Lilly Co Eli |
MET antitest hatóanyag konjugátumok
|
|
WO2018221969A1
(en)
|
2017-05-30 |
2018-12-06 |
Chong Kun Dang Pharmaceutical Corp. |
A novel anti-c-met antibody and use thereof
|
|
US20200129633A1
(en)
|
2017-06-06 |
2020-04-30 |
Jiangsu Hengrui Medicine Co., Ltd. |
Pharmaceutical composition comprising c-met antibody-drug conjugate and use thereof
|
|
JP7264831B2
(ja)
|
2017-06-15 |
2023-04-25 |
ディベロップメント センター フォー バイオテクノロジー |
抗ｇｌｏｂｏ ｈ抗体を含有する抗体－薬物コンジュゲートおよびその使用
|
|
CN118580366A
(zh)
|
2017-08-09 |
2024-09-03 |
美勒斯公司 |
结合EGFR和cMET的抗体
|
|
KR20190038174A
(ko)
|
2017-09-29 |
2019-04-08 |
서울대학교산학협력단 |
항 c-Met 항체 및 이의 용도
|
|
KR20190038173A
(ko)
|
2017-09-29 |
2019-04-08 |
서울대학교산학협력단 |
항 c-Met 항체 및 이의 용도
|
|
US20220040319A1
(en)
|
2019-02-21 |
2022-02-10 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating ocular cancer using anti-met antibodies and bispecific antigen binding molecules that bind met
|
|
US11896682B2
(en)
|
2019-09-16 |
2024-02-13 |
Regeneron Pharmaceuticals, Inc. |
Radiolabeled MET binding proteins for immuno-PET imaging and methods of use thereof
|
|
CN116888123B
(zh)
|
2021-02-09 |
2026-02-24 |
微境生物医药科技(上海)有限公司 |
用于adc制备的喜树碱衍生物
|